KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Change in Inventory (2017 - 2025)

Historic Change in Inventory for Twist Bioscience (TWST) over the last 9 years, with Q4 2025 value amounting to $4.6 million.

  • Twist Bioscience's Change in Inventory rose 92410.71% to $4.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $9.4 million, marking a year-over-year increase of 22803.27%. This contributed to the annual value of $4.2 million for FY2025, which is 15295.52% up from last year.
  • Latest data reveals that Twist Bioscience reported Change in Inventory of $4.6 million as of Q4 2025, which was up 92410.71% from $2.4 million recorded in Q3 2025.
  • In the past 5 years, Twist Bioscience's Change in Inventory ranged from a high of $10.6 million in Q3 2021 and a low of -$4.7 million during Q1 2023
  • In the last 5 years, Twist Bioscience's Change in Inventory had a median value of -$523000.0 in 2024 and averaged $976150.0.
  • In the last 5 years, Twist Bioscience's Change in Inventory soared by 130857.14% in 2021 and then tumbled by 44670.78% in 2025.
  • Quarter analysis of 5 years shows Twist Bioscience's Change in Inventory stood at $8.4 million in 2021, then crashed by 37.4% to $5.3 million in 2022, then tumbled by 122.74% to -$1.2 million in 2023, then surged by 53.37% to -$560000.0 in 2024, then soared by 924.11% to $4.6 million in 2025.
  • Its Change in Inventory was $4.6 million in Q4 2025, compared to $2.4 million in Q3 2025 and $5.1 million in Q2 2025.